Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (11)

2024

  1. Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution

    Mycoses, Vol. 67, Núm. 3

  2. Fluconazole-resistant Candida parapsilosis: fast detection of the Y132F ERG11p substitution, and a proposed microsatellite genotyping scheme

    Clinical Microbiology and Infection, Vol. 30, Núm. 11, pp. 1447-1452

2023

  1. Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates

    Clinical Microbiology and Infection, Vol. 29, Núm. 12, pp. 1604.e1-1604.e6

2022

  1. Evidence of Fluconazole-Resistant Candida parapsilosis Genotypes Spreading across Hospitals Located in Madrid, Spain and Harboring the Y132F ERG11p Substitution

    Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 8

  2. Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the COVID-19 Pandemic

    Open Forum Infectious Diseases, Vol. 9, Núm. 11

2020

  1. Comparison of the Safety and Tolerance Profile of Micafungin with that of Other Echinocandins and Azoles in Patients with Pre-existing Child–Pugh B or C Liver Disease: A Case–Control Retrospective Study

    Infectious Diseases and Therapy, Vol. 9, Núm. 1, pp. 151-163

2018

  1. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: A prospective pilot study

    Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv6-iv12

  2. T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study

    Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv13-iv19

2017

  1. Is routine ophthalmoscopy really necessary in candidemic patients?

    PLoS ONE, Vol. 12, Núm. 10

  2. No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins

    Diagnostic Microbiology and Infectious Disease, Vol. 88, Núm. 2, pp. 141-144

2015

  1. Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: RESULTS from a population-based surveillance in Spain

    Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 491.e1-491.e10